Specialized type I topoisomerases catalyze DNA strand transfer during site-specific recombination in prokaryotes and fungi. As a rule, the site specificity of these systems is determined by the DNA binding and cleavage preference of the topoisomerase per se. The Mr 32,000 topoisomerase I encoded by vaccinia virus (a member of the eukaryotic family of "general" type I enzymes) is also selective in its interaction with DNA; binding and cleavage occur in vitro at a pentameric motif 5'-(C or T)CCTT in duplex DNA. Expression of vaccinia virus DNA topoisomerase I in a A lysogen of Escherchia coli promotes int-independent excisive recombination of the prophage. To address whether the topoisomerase directly catalyzes DNA strand transfer in vivo, the recombination junctions of plaque-purified progeny phage were cloned and sequenced. In five of six distinct excision events examined, a topoisomerase cleavage sequence is present in one strand of the DNA duplex of both recombining partners. Recombination entails no duplication, insertion, or deletion of nucleotides at the crossover points, consistent with excision via conservative strand exchange at sites of topoisomerase cleavage. Three of these five recombination events are distinguished by the presence of direct repeats at the parental half-sites that extend beyond the pentameric cleavage motif, suggesting that sequence homology may facilitate excision. The data are consistent with a model in which vaccinia topoisomerase catalyzes reciprocal strand transfer, leading to the formation of a nonmiigrating Holliday junction, the resolution of which can lead to excisive recombination.
Step-wise breakage and rejoining of DNA strands via a covalent protein-DNA intermediate is the unifying mechanistic feature of all DNA topoisomerases (1) . The repertoire of topological interconversions catalyzed by these enzymes in vitro is broad and includes relaxation, supercoiling, catenation, decatenation, knotting, and unknotting of circular DNA substrates. In each of these topoisomerizations, strand breakage is followed by intramolecular religation across the same phosphodiester bond that was originally cleaved. Thus, the integrity of the genome can be expected to be maintained when such reactions occur in vivo-e.g., in DNA replication, chromosome segregation, and transcription. However, when a topoisomerase rejoins a covalently bound DNA terminus to a new acceptor strand, the effect is to generate a recombinant molecule.
The question of whether and how topoisomerases participate in recombination has been pursued intensively. Elegant genetic and biochemical studies of site-specific recombination systems (e.g., A phage integrase, Tn3 resolvase, Saccharomyces cerevisiae FLP recombinase, P1 phage Cre protein) have established clearly that specialized type I DNA topoisomerases (recombinases) directly catalyze recombinational strand transfer (2, 3) . In these systems, the sitespecificity of the recombination event correlates with the nucleotide sequence specificity of the purified recombinase enzyme in DNA binding and/or formation of the covalent enzyme-DNA intermediate in vitro. Topoisomerase activity of these proteins, assayed by relaxation of supercoiled DNA, displays selectivity for substrates containing the recombination sites or homologs thereof.
A role in recombination has also been invoked for the ubiquitous "general" topoisomerases. Type II enzymes can promote recombination in vitro; this reaction is illegitimate (involving nonhomologous sequences of DNA), and the recombinant molecules often have insertions and deletions of DNA (4) . Ikeda (4) has proposed that an exchange of enzyme subunits between two DNA-bound topoisomerase molecules [having a2-or (af3)2-subunit symmetry] is the basis of this event.
The eukaryotic type I topoisomerase, a monomeric enzyme, has been implicated in illegitimate recombination in mammalian somatic cells (5) . The biochemical foundation for such a role is the demonstration that purified mammalian topoisomerase I under some conditions can catalyze religation of a cleaved DNA strand to a heterologous acceptor molecule in vitro (6) . Physiological relevance is suggested by the findings that the nucleotide sequences surrounding exchange sites for simian virus 40 prophage excision (a model illegitimate event) resemble the loosely conserved cleavage motif of cellular topoisomerase I, and that the sequences at the crossovers are actually cleaved in vitro by the purified enzyme (7) . Topoisomerase I is also implicated in the illegitimate integration of hepadnavirus DNA into the cellular genome (8) .
A viral model for eukaryotic topoisomerase I function is afforded by vaccinia virus, which replicates in the cytoplasm of mammalian cells. Vaccinia encodes and encapsidates within the infectious particle a type I topoisomerase that is functionally and structurally similar to its cellular counterpart (9, 10) . The vaccinia topoisomerase, a Mr 32,000 monomeric enzyme, is essential for replication of the virus in cultured cells (11) . While the precise role of the topoisomerase during vaccinia infection remains obscure, there is some indication that this enzyme may play a role in recombination. I have shown previously that expression of the vaccinia topoisomerase gene in a heterologous system (Escherichia coli) promotes int-independent excision of a resident A prophage (12) . Restriction analysis of 10 recombinant A phage genomes (representing six different recombination events) revealed that in no instance was excision accomplished by site-specific recombination between attL and attR; instead, excision entailed gross alterations of the DNA structure around the phage att site, suggesting that topoisomerase I-dependent recombination is illegitimate (12) . That study provided strong evidence that a eukaryotic topoisomerase I promotes recombination in vivo by its correlation of the presence of topoisomerase I activity with the occurrence of a particular
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A distinctive feature of the vaccinia topoisomerase I (vis a' vis the cellular enzyme) is its sequence-specific interaction with duplex DNA in vitro. Mapping of sites of cleavable complex formation in plasmid DNA has revealed a conserved oligopyrimidine motif, YCCTT in which Y is C or T, immediately 5' to the site of covalent adduct formation between a 3' phosphate of the incised DNA strand and the active-site tyrosine (Tyr-274) of the topoisomerase polypeptide (13) (14) (15) . Accordingly, if vaccinia topoisomerase were actually catalyzing recombinational strand exchange during A prophage excision in vivo, then the sequences at the recombination junctions should reflect the specificity of the purified enzyme in vitro. I report herein that this is indeed the case. In five of six distinct excision events examined, a topoisomerase cleavage sequence is present in one strand of the DNA duplex of both recombining partners. The data are consistent with a model in which vaccinia topoisomerase I catalyzes reciprocal conservative strand exchange to generate a nonmigrating Holliday junction, the resolution of which can result in prophage excision. Topoisomerase may play a similar role as a component of the homologous recombination system induced in the cytoplasm of vaccinia infected cells.
RESULTS
Precise Mapping of the Sites of Topoisomerase-Dependent Prophage Excision. Expression of vaccinia topoisomerase in a ADE3 lysogen of E. coli BL21 results in recA-dependent prophage induction accompanied by int-independent excision of the phage DNA from the bacterial chromosome (12) . The structure of the ADE3 prophage (16) and relevant flanking markers in the bacterial genome are shown in Fig. 1 . The prophage is displayed such that the regions involved in topoisomerase-dependent excisive recombination are closely approximated, with intervening phage DNA looping out between these regions (Fig. 1) . Recombination sites were located for each of 10 plaque-purified progeny phage by comparative restriction mapping (12) and subsequent sequencing of cloned DNA fragments containing the recombination junctions (Fig. 1) phages 4, 6, 8, and 9) and most likely represented sisters, given that these viruses were plaque-purified from the same lysate of isopropyl thiogalactoside-induced bacteria. Each recombination half-site recombined uniquely with one other half-site.
Nucleotide Sequences at Recombination Sites. The nucleotide sequence of each of the recombination junctioncontaining DNA fragments (cloned into pUC18) was determined by dideoxy sequencing using synthetic oligonucleotide primers (17) . The data were in excellent agreement with available GenBank sequences for bacteriophage A, the E. coli lac operon, bacteriophage T7 gene I (encoding RNA polymerase), the E. coli bio operon, and the E. coli uvrB gene, these being the regions of the prophage and flanking loci within which DNA crossover occurred (Fig. 1) . The sequences ofthe progeny phage in the immediate vicinity ofthe crossover points are shown in Fig. 2 and are displayed in alignment with the sequences of the recombining parental half-sites (shown above and below the phage sequence) as they exist in the uninduced lysogen.
The basic features of the recombination process are revealed by inspection of the sequence of progeny phage 4 and its half-sites ( Fig. 2 ). Crossover occurred in this case within a 9-base pair (bp) direct repeat sequence, 5'-GCCCTTCGC, present in both recombining partners, which included a pentamer cleavage motif (5'-CCCTT) for vaccinia topoisomerase. Recombination entailed no duplication, insertion, or deletion of nucleotides at the crossover points. Thus, excision likely occurred via conservative strand exchange within the direct repeat.
Crossover 4 .6% of the input DNA. Cleavage was quite specific for the top strand oligonucleotide; no adduct formation occurred with the labeled bottom strand oligomer in either single-stranded (Fig. 3, lane 6 ) or duplex forms (Fig. 3,  lane 8) . Thus, the recombining half-site was indeed a substrate for strand-specific cleavage in vitro by vaccinia topoisomerase. The crossover point in the other parental half-site for excision of progeny phage 7 was located 3' to the T residue in a 5'-TTCTT sequence in the A prophage (Fig. 2) . Oligonucleotides containing a C -* T substitution at position +4 were shown previously to be excellent substrates for cleavage by purified topoisomerase (15 (15) . DNA It was shown previously that a C --A change at position +3 drastically reduced the formation of cleavable complex between purified topoisomerase and a model oligonucleotide substrate containing a sequence of pUC19 DNA (14) . It has been suggested that the degree to which point mutations in the pentamer motif affect cleavage efficiency may be dependent on flanking sequence context (14, 15) . Thus, an oligonucleotide corresponding exactly to the T7 polymerase gene sequence at the recombining half-site (5'-CACCGTAAGCCAGCfAIIGACCAG) was synthesized (along with its exact complement) and tested in cleavable complex formation. The results were essentially identical to those depicted in Fig.  3 . Only the CCATT-containing oligonucleotide was cleaved, and only in duplex form. No complementary strand cleavage was observed (data not shown). The extent of cleavage was 2.2% of input DNA, which was less than that of the standard pUC19 oligonucleotide sequence [typically 30-40o cleavage under identical conditions (data not shown)]. Clearly, however, the half-site was cleaved in vitro with the appropriate strand-specificity.
The remaining phage, progeny 2, was excised within a 4-bp direct repeat CGCA. No vaccinia topoisomerase cleavage motif or close variant thereof was present at this crossover point (Fig. 2) (19, 20) . Although illegitimate recombination in E. coli does not require RecA, the frequency of deletion formation has been reported to be decreased significantly by recA mutations (20 (21) . FLP recombinase, too, is a type I topoisomerase mechanistically similar to eukaryotic topoisomerase I. Analysis of recombination intermediates suggests that pairing of FLP target sites is mediated by protein-protein interactions between recombinase molecules bound to each site (21) . Interaction between resolvase molecules is essential for synapsis in y8 transposition (22) .
The excision of the ADE3 prophage promoted by vaccinia topoisomerase can be similarly modeled as a site-specific recombination event in which only one of the two pairs of strand exchanges required for excision is catalyzed by the topoisomerase (Fig. 4) (23, 24) .
An alternative pathway is the deletion model proposed by Champoux and colleagues (5, 7) for illegitimate recombination by mammalian topoisomerase I. In this case, vaccinia topoisomerase molecules would form covalent intermediates opposite preexisting nicks in the nonscissile DNA strand.
This effectively would lead to double-strand breaks at the parental half-sites with liberation of a linear progeny genome containing one covalently bound topoisomerase molecule at the 3' end. Formation of circular DNA would occur via intramolecular religation to the 5' OH terminus of the linear DNA.
The deletion model is remarkable for its simplicity and because there is no need to posit the involvement of any proteins other than the topoisomerase. It predicts that the utilization of a particular cleavage motif for recombination would be governed by the existence of an appropriate lesion on the nonscissile strand. This would likely be a nick located within a few nucleotides from the site of topoisomerase cleavage. A more complex variation of the deletion model might involve action of a bacterial enzyme that cleaves DNA across from covalently bound topoisomerase, thus obviating the requirement for preexisting nicks.
There are certain features of the topoisomerase-mediated recombination reaction for which the deletion model does not account or else fails to predict. Most striking is the presence of direct repeats at the parental half-sites that extend beyond the pentameric cleavage motif. This occurs in three of the five recombination events (progeny phages 4, 1, and 5) in which topoisomerase is implicated directly. The inference that sequence homology may facilitate excision is in line with the site-specific recombinase model which, perforce, entails the need for synapsis prior to strand exchange. Second, it might be anticipated from the deletion model that one would encounter progeny phage that have lost variable amounts of sequence information at the left parental half-site 3' to the point of topoisomerase cleavage; this would result from hypothetic exonuclease action at the unprotected 5' end of the excised linear DNA. That this is not seen may be a function of the small sample size examined; nonetheless, if the deletion model applies, religation must be fairly efficient or else the hypothetical exonuclease does not impact on the process. The recombinase model mandates conservation of sequence at the crossover point. (25, 26) . Parks and Evans (27) suggest that heteroduplex DNAs are formed in the process. Nothing is known about the identity of the viral (or host) proteins involved in poxvirus-mediated recombination. I propose a simple topoisomerase-dependent model for vaccinia homologous recombination mediated by three virusencoded components: (i) a protein that discriminates and approximates homologous DNA sequences; (ii) a strand transferase (vaccinia topoisomerase I) that catalyzes formation of Holliday intermediates: and (iii) an endonuclease capable of resolving the Holliday junctions. There are 542 copies of the YCCTT topoisomerase cleavage sequence within the 192-kbp vaccinia genome (28), providing ample potential sites for topoisomnerase action.
A strong candidate for the role of Holliday resolution is the DNA endonuclease encapsidated within the vaccinia virus particle. This enzyme, a homodimer of Mr 50,000 subunits, has been shown (29) to cleave negatively supercoiled DNA at specific sites (presumed to be sites of cruciform extrusion) and actually to rejoin the cleaved strand (in the absence of a high-energy cofactor) to yield a covalently continuous hairpin-ended linear product. This "nicking-joining" enzyme has been hypothesized to act in resolving the hairpin telomeres of the vaccinia genome (30) . I propose a more general function for this protein in resolution of intermediates in homologous recombination (apart from or in addition to the posited involvement in telomere resolution). Homologous recombination and telomere resolution are distinguishable in vivo on genetic grounds. Vaccinia temperature-sensitive mutants that are defective in the synthesis of late proteins are unable to resolve telomeres, yet are proficient in homologous recombination (26, 31) . Conceivably, the two pathways might overlap in their requirements for certain viral gene products. The sensitivity oftelomere resolution to defective late protein synthesis may be explained by (i) a requirement for one or more late viral proteins unique to the telomere pathway or (ii) a requirement for one or more proteins common to both pathways that are present at limiting concentrations (i.e., sufficient for recombination) prior to onset of late protein synthesis, but which must accumulate to higher levels (by new synthesis at late times) to catalyze telomere resolution. The latter scenario may pertain to the topoisomerase and/or the nicking-joining enzyme, both of which are believed to be synthesized late in infection but are present at early times by virtue of their encapsidation within the infecting virion particle.
Assessment of the role of topoisomerase in vaccinia recombination is hampered by the lack ofconditional mutations in the topoisomerase gene; the function ofthe nicking-joining enzyme is even more obscure insofar as the viral-gene encoding this protein has not yet been identified. The existence of a homologous pairing protein encoded by vaccinia is only speculative. Nonetheless, the topoisomerase-centered scheme for vaccinia homologous recombination provides a framework for future in vitro experiments using model recombination substrates and intermediates.
